| Article Dump |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diseases > Could I Have Fibromyalgia Pain? |
|
Article Dump - Could I Have Fibromyalgia Pain?
The term fibromyalgia has been derived from the Latin and Greek words; in which fibra is a Latin word which means fiber an According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product d the Greek words myo and algos stands for pain and muscle respectively. This disorder has been the object of study since ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in the 1800s and earlier it was also called as muscular rheumatism and fibrositis. But the current name has been given to th lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e condition by Muhammad Yunus and his colleagues in 1981. The meaning thus refers to the pain in the muscles and the tissu here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe es in the body. The acronyms like FM or FMS are also sometimes used to indicate the disorder. The condition of fibromyalgi d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro a is characterized by pain in the different parts of the body. The pain may be located in specific parts of the body like ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc the joints and bones. The sufferer may also feel fatigue. The study about fibromyalgia suggests that the genes may be the easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi arriers of the disorder. Women are more at the risk of having fibromyalgia than men and the ratio confirms this fact, the nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ratio for fibromyalgia is 9:1 which has been declared by the American College of Rheumatology. The disorder of fibromyalg and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ia is found in two to three percent of the total population. The condition affects persons who are in the age group of twe ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nty to fifty years. The disorder has not yet been fully understood by scientists and investigators and the fortunate thing ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a about this disorder is that it does not develop over a period of time and is not very serious at all. Symptoms: The sym dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ptoms of the fibromyalgia condition are the patient’s sensitivity to any type of mild or simple touch. The sufferer of fib cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin romyalgia is in chronic pain in the various regions of the body. The skin in the patients of fibromyalgia becomes very sen tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen itive as well; the skin may experience a needle like sharp tingling. Other signs of this disease include pain in the nerve t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s, weakness in the joints of the body, and continued pain in the muscles. The affected person also has a sleep disturbance ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust and the condition of insomnia is the classic symptom of fibromyalgia. The diagnosis is fibromyalgia is not very well def y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ined but the American college of rheumatology has laid down certain criteria for the diagnosis of fibromyalgia which are k . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nown as the ACR 1990, since the rules were laid down in 1990. The criteria lays stress on the condition of widespread pain elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip which can continue for three months or more than that. There are also 18 tender points by which the diagnosis can be done tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Get a Good View of French Property Motorola KRZR - The Absolute Charmer
|